Article-Journal | Ville Langénhttps://villelangen.com/publication_types/article-journal/Article-JournalHugo Blox Builder (https://hugoblox.com)en-usTue, 07 Apr 2026 00:00:00 +0000https://villelangen.com/media/icon_hu7353780716416406245.pngArticle-Journalhttps://villelangen.com/publication_types/article-journal/Trends in Polypharmacy Among Patients With Atrial Fibrillation: A Report From the Finnish AntiCoagulation in Atrial Fibrillation Nationwide Cohort Studyhttps://villelangen.com/peer/kiuru-trends-polypharmacy-af-2026/Tue, 07 Apr 2026 00:00:00 +0000https://villelangen.com/peer/kiuru-trends-polypharmacy-af-2026/Machine Learning-Based Prediction of Drug-Induced QTc Changes in a Large Finnish Biobank Cohorthttps://villelangen.com/peer/langen-ml-qtc-finngen-2026/Thu, 01 Jan 2026 00:00:00 +0000https://villelangen.com/peer/langen-ml-qtc-finngen-2026/Estimating the Stroke Risk Threshold for Initiating Non-Vitamin K Antagonist Oral Anticoagulation in Atrial Fibrillation: Markov Decision Model Analysishttps://villelangen.com/peer/winsten-estimating-stroke-risk-2025/Wed, 27 Aug 2025 00:00:00 +0000https://villelangen.com/peer/winsten-estimating-stroke-risk-2025/Associations between gut microbiome and circulating cytokines: a cross-sectional analysis in the FINRISK 2002 population cohorthttps://villelangen.com/peer/diab-associations-gut-microbiome-2025/Tue, 26 Aug 2025 00:00:00 +0000https://villelangen.com/peer/diab-associations-gut-microbiome-2025/Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort studyhttps://villelangen.com/peer/jalli-venous-thromboembolisms-stroke-2025/Mon, 04 Aug 2025 00:00:00 +0000https://villelangen.com/peer/jalli-venous-thromboembolisms-stroke-2025/Heart Failure and Stroke Risk in Atrial Fibrillation: Temporal Trends From a Nationwide Cohort Studyhttps://villelangen.com/peer/jalli-heart-failure-stroke-2025/Tue, 15 Jul 2025 00:00:00 +0000https://villelangen.com/peer/jalli-heart-failure-stroke-2025/Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patientshttps://villelangen.com/peer/isotalo-effects-cholinesterase-inhibitor-2025/Tue, 06 May 2025 00:00:00 +0000https://villelangen.com/peer/isotalo-effects-cholinesterase-inhibitor-2025/Net Benefit of Anticoagulation in Subclinical Device-Detected Atrial Fibrillationhttps://villelangen.com/peer/winsten-net-benefit-subclinical-af-2025/Thu, 01 May 2025 00:00:00 +0000https://villelangen.com/peer/winsten-net-benefit-subclinical-af-2025/Association between educational attainment and blood pressure in older adults: a study of two Finnish generational cohorts born 20 years aparthttps://villelangen.com/peer/laati-association-educational-attainment-2025/Tue, 22 Apr 2025 00:00:00 +0000https://villelangen.com/peer/laati-association-educational-attainment-2025/Clinical outcomes of atrial fibrillation screening: a meta-analysis of randomized controlled trialshttps://villelangen.com/peer/langen-af-screening-meta-analysis-2025/Sat, 25 Jan 2025 00:00:00 +0000https://villelangen.com/peer/langen-af-screening-meta-analysis-2025/Myths and challenges around anticoagulation in atrial fibrillation: A practicing clinician's perspectivehttps://villelangen.com/peer/airaksinen-myths-anticoagulation-af-2025/Tue, 21 Jan 2025 00:00:00 +0000https://villelangen.com/peer/airaksinen-myths-anticoagulation-af-2025/Lack of Association Between Sodium Intake and Cytokine Levelshttps://villelangen.com/peer/wistrand-sodium-cytokine-2024/Thu, 12 Dec 2024 00:00:00 +0000https://villelangen.com/peer/wistrand-sodium-cytokine-2024/The natural history of hypertension in older adults: a study of two Finnish generational cohorts born 20 years aparthttps://villelangen.com/peer/laati-natural-history-hypertension-2024/Mon, 24 Jun 2024 00:00:00 +0000https://villelangen.com/peer/laati-natural-history-hypertension-2024/Temporal Trends in Hypertension-Related Ischemic Stroke Risk in Atrial Fibrillation from 2007 to 2018: A Nationwide Cohort Studyhttps://villelangen.com/peer/teppo-temporal-2024/Fri, 01 Mar 2024 00:00:00 +0000https://villelangen.com/peer/teppo-temporal-2024/Trends in Positive Life Orientation Among 70-Year-Olds: A Comparison of Two Finnish Cohorts Born 20 Years Aparthttps://villelangen.com/peer/langen-trends-2024/Thu, 01 Feb 2024 00:00:00 +0000https://villelangen.com/peer/langen-trends-2024/The associations of self-reported salt-intake and spot urine sodium with home blood pressure.https://villelangen.com/peer/wistrand-associations-2023/Fri, 01 Dec 2023 00:00:00 +0000https://villelangen.com/peer/wistrand-associations-2023/Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation: A Nationwide Cohort Studyhttps://villelangen.com/peer/teppo-oral-2023/Sun, 01 Oct 2023 00:00:00 +0000https://villelangen.com/peer/teppo-oral-2023/EKG-löydökset vaikeuttavat muistisairauden lääkehoitoahttps://villelangen.com/peer-reviewed-finnish-publications/ranta-ekg-loydokset-2023/Sun, 01 Jan 2023 00:00:00 +0000https://villelangen.com/peer-reviewed-finnish-publications/ranta-ekg-loydokset-2023/Mystinen leukasärky, kaksoiskuvat ja hajoavat punasoluthttps://villelangen.com/peer-reviewed-finnish-publications/laiho-mystinen-2023/Sun, 01 Jan 2023 00:00:00 +0000https://villelangen.com/peer-reviewed-finnish-publications/laiho-mystinen-2023/Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort studyhttps://villelangen.com/peer/teppo-rural-urban-2022/Sat, 01 Jan 2022 00:00:00 +0000https://villelangen.com/peer/teppo-rural-urban-2022/Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trialhttps://villelangen.com/peer/makela-effects-2021/Fri, 01 Jan 2021 00:00:00 +0000https://villelangen.com/peer/makela-effects-2021/Nostaako krooninen tulehdus verenpainetta?https://villelangen.com/peer-reviewed-finnish-publications/langen-nostaako-2021/Fri, 01 Jan 2021 00:00:00 +0000https://villelangen.com/peer-reviewed-finnish-publications/langen-nostaako-2021/Usability of two brief questions as a screening tool for domestic violence and effect of #MeToo on prevalence of self-reported violencehttps://villelangen.com/peer/kero-domestic-violence-screening-2020/Fri, 16 Oct 2020 00:00:00 +0000https://villelangen.com/peer/kero-domestic-violence-screening-2020/Longitudinal blood pressure patterns and cardiovascular disease risk.https://villelangen.com/peer/nuotio-longitudinal-2020/Sat, 01 Feb 2020 00:00:00 +0000https://villelangen.com/peer/nuotio-longitudinal-2020/Age of Hypertension Onset: Overview of Research and How to Apply in Practicehttps://villelangen.com/peer/suvila-age-2020/Wed, 01 Jan 2020 00:00:00 +0000https://villelangen.com/peer/suvila-age-2020/Home and office blood pressure measurements as determinants of kidney disease in the general population: The Finn-Home Study.https://villelangen.com/peer/siven-home-2019/Tue, 01 Jan 2019 00:00:00 +0000https://villelangen.com/peer/siven-home-2019/Electrocardiographic predictors of atrial fibrillation in nonhypertensive and hypertensive individualshttps://villelangen.com/peer/lehtonen-electrocardiographic-2018/Sat, 01 Sep 2018 00:00:00 +0000https://villelangen.com/peer/lehtonen-electrocardiographic-2018/Relation of blood pressure and organ damage: Comparison between feasible, noninvasive central hemodynamic measures and conventional brachial measureshttps://villelangen.com/peer/lindroos-relation-2018/Fri, 01 Jun 2018 00:00:00 +0000https://villelangen.com/peer/lindroos-relation-2018/Thyroid-stimulating hormone and risk of sudden cardiac death, total mortality and cardiovascular morbidity.https://villelangen.com/peer/langen-thyroid-stimulating-2018/Mon, 01 Jan 2018 00:00:00 +0000https://villelangen.com/peer/langen-thyroid-stimulating-2018/Incidence rates, correlates, and prognosis of electrocardiographic P-wave abnormalities – a nationwide population-based studyhttps://villelangen.com/peer/lehtonen-incidence-2017/Wed, 01 Nov 2017 00:00:00 +0000https://villelangen.com/peer/lehtonen-incidence-2017/Outcome-Driven Thresholds for Increased Home Blood Pressure Variabilityhttps://villelangen.com/peer/juhanoja-outcome-driven-thresholds-2017/Mon, 13 Feb 2017 00:00:00 +0000https://villelangen.com/peer/juhanoja-outcome-driven-thresholds-2017/Home versus office blood pressure: longitudinal relations with left ventricular hypertrophy: the Finn-Home study.https://villelangen.com/peer/siven-home-2017/Wed, 01 Feb 2017 00:00:00 +0000https://villelangen.com/peer/siven-home-2017/Association of thyroid-stimulating hormone with lipid concentrations: an 11-year longitudinal study.https://villelangen.com/peer/langen-association-2017/Sun, 01 Jan 2017 00:00:00 +0000https://villelangen.com/peer/langen-association-2017/Association between thyroid-stimulating hormone and blood pressure in adults: an 11-year longitudinal studyhttps://villelangen.com/peer/langen-association-2016/Sun, 01 May 2016 00:00:00 +0000https://villelangen.com/peer/langen-association-2016/Prediction of Blood Pressure and Blood Pressure Change With a Genetic Risk Score.https://villelangen.com/peer/niiranen-prediction-2016/Tue, 01 Mar 2016 00:00:00 +0000https://villelangen.com/peer/niiranen-prediction-2016/HDL-hypoteesi valtimotautien tutkimuksessa ja hoidossa – pettymysten jälkeen edessä renessanssi?https://villelangen.com/other-publications/langen-hdl-hypoteesi-2016/Fri, 01 Jan 2016 00:00:00 +0000https://villelangen.com/other-publications/langen-hdl-hypoteesi-2016/Thyroid-stimulating hormone reference range and factors affecting it in a nationwide random samplehttps://villelangen.com/peer/langen-thyroid-stimulating-2014/Mon, 01 Dec 2014 00:00:00 +0000https://villelangen.com/peer/langen-thyroid-stimulating-2014/